Calendar of events

March 28 – 30, 2023 | London

2023 is shaping up to be a landmark year for the protein degradation community.

The Targeted Protein Degradation Europe Summit returns to London for its 3rd year, providing a central touchpoint to obtain critical updates and learnings from 30+ key Industry and academic speakers.

Join this 160+ TPD community, including Beacon’s Lead TPD Analyst, Rachel East, for ‘A Review of the TPD Disease Landscape’, to gain insight into the latest advancements of the degrader community, as together we work to advance degraders closer to the clinic and accelerate the progression of next-generation degraders.

March 28 – 30, 2023 | San Diego, CA

The 8^th Innate Killer Summit returns to San Diego in March to cement your end-to-end education in innate immune therapeutics. This year’s meeting brings critical insights and updates for your whole team, with content tracks spanning preclinical development, clinical translation, CMC, process development, and clinical scale manufacturing.

Engage in interactive discussion and network with 250+ innate immune experts from 120+ companies to realize lasting clinical response with next-generation engineering to provide off-the-shelf delivery for more patients globally.

Providing a landscape review of innate immune therapies, is Beacon’s own Research Analyst, Flavio Lima Bianchi, where he will take a deep dive into the drug landscape including analysis of drug developers and innovative technologies and provide a look to the future based on expected regulatory events

April 24 – 26, 2023 | Amsterdam, Netherlands

Supercharge the Clinical Translation of Efficacious Neoantigen Vaccines & Immunotherapies for Patients in Need

The 6th Annual Neoantigen Summit Europe returns to Amsterdam, as the only summit in Europe dedicated to advancing exclusive tumour antigen discovery and personalised therapeutic development within the world of immunotherapy.

• Examine critical factors for successful translation of personalised therapies into the clinic with Geneos Therapeutics, Curvac, Transgene, Nykode Therapeutics and Immunetune
• Enhance various methods to increasing the precision accuracy of identifying neoantigens with The Netherlands Cancer Institute and Precision BioLogic
• Delve into the how to overcome specific challenges in vaccine manufacturing for targeting neoantigens with BioNTech

Join 150+ experts at the forum, including Beacon’s Cancer Vaccine Research Lead, Megan Taylor, as they navigate validation of neoantigen targets and review methodologies/technologies to support with translating neoantigen-based studies effectively to the clinic.

April 25 – 27, 2023 | Boston, MA

2022 was another great year for cell engager antibody therapies, and since the approval of Tecytinib, 2023 looks like it will be the year for cell engagers!

The 5th Cell Engager Summit returns to Boston as the only industry-led meeting bringing together 80+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference workshops to delve into the biggest challenges cell engager therapeutics face. Breaking into the solid tumor, preventing CRS and maximizing the quality of insights we gain from preclinical modeling.

Join your colleagues, including our Bispecific Research Lead, Shailee Patel, at the most comprehensive cell engager event, leaving no stone unturned, this highly focused meeting covers everything translational and clinical in greater depth and detail than any before it.